is victoza a glp-1 drug Generic Liraglutide (Victoza) Becomes First Generic Receptor Agonist GLP-1 Drugs Could Double Risk

122,124 However, increasing evidence is reporting the involvement of peptide drugs in the occurrence of CYP or transporter-mediated DDIs

While injectable GLP-1 treatments remain the leading licensed choice for weight loss in the UK today, oral alternatives are quickly closing the gap

Besides, if its good enough for the queen of comedy and the Tesla-driving martian man, its got to be worth talking about, right

10.1113/jphysiol.1902.sp000920 7 BellG

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks